Cargando…
DLC2 operates as a tumor suppressor gene in breast cancer via the RhoGTPase pathway
Deleted in liver cancer 2 (DLC2) is a tumor suppressor, associated with various types of cancer. The aim of the present study was to analyze the expression of DLC2 in breast cancer, its clinical significance and its effect on breast cancer cell behavior. The expression of DLC2 was evaluated by immun...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350186/ https://www.ncbi.nlm.nih.gov/pubmed/30719106 http://dx.doi.org/10.3892/ol.2018.9874 |